Globe NewsWire News Distribution Service

Details

Written by Globe NewsWire Press Releases

Category: Globe NewsWire News Distribution Service

Published: 15 June 2024

Created: 15 June 2024

Last Updated: 15 June 2024

New York, United States , June 15, 2024 (GLOBE NEWSWIRE) -- The Global Companion Diagnostics Market Size is to Grow from USD 7.12 Billion in 2023 to USD 23.12 Billion by 2033, at a CAGR of 12.50% during the projected period.

Posted: 2024-06-15 06:00:00

Get Full News Story On GlobeNewsWire Press Release Service

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

• Prev
• Next

Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Global Companion Diagnostics Market Size To Exceed USD 23.12 Billion By 2033 | CAGR Of 12.50% - Newscast

FDA Approves MI Cancer Seek as Companion Diagnostic for Adult and Pediatric Patients With Cancer

Sat, 09 Nov 2024 07:19:00 GMT MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from treatment with targeted therapies.

Caris Life Sciences nabs FDA approval for multicancer companion diagnostic

Wed, 06 Nov 2024 08:16:59 GMT The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, across multiple oncology indications.

Companion Diagnostics Market Trends, Transforming Personalized Medicine Through Targeted Therapies and Innovative Biomarker Discovery

Mon, 28 Oct 2024 04:28:00 GMT The report offers a detailed examination of industry trends and developments shaping the growth of the Companion Diagnostics market. It also provides a comprehensive analysis and forecast of the ...

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib

Tue, 22 Oct 2024 05:00:00 GMT This patent represents a significant step forward in securing Allarity’s market position for stenoparib and the Stenoparib DRP companion diagnostic ... has exclusive global rights for the ...

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib

Tue, 22 Oct 2024 01:01:00 GMT European Patent Office to grant a patent for DRP ® companion diagnostic for Allarity’s ... Allarity has exclusive global rights for the development and commercialization of stenoparib, which ...